115 related articles for article (PubMed ID: 34886845)
61. Modeling and Mathematical Analysis of the Dynamics of HPV in Cervical Epithelial Cells: Transient, Acute, Latency, and Chronic Infections.
Sierra-Rojas JC; Reyes-Carreto R; Vargas-De-León C; Camacho JF
Comput Math Methods Med; 2022; 2022():8650071. PubMed ID: 36050998
[TBL] [Abstract][Full Text] [Related]
62. Inhibitory mechanism of ternary fusion protein MSIK on HPV virus.
Hu HF; Zhao QH; Sang YF
Eur Rev Med Pharmacol Sci; 2022 Sep; 26(17):6340-6343. PubMed ID: 36111935
[TBL] [Abstract][Full Text] [Related]
63. Drug Formulations for Localized Treatment of Human Papillomavirus-Induced Lesions.
Maocha IG; Carvalho J; Lopes-Nunes J; Rosado T; Gallardo E; Tomás M; Palmeira-de-Oliveira A; Palmeira-de-Oliveira R; Martinez-de-Oliveira J; Campello MPC; Paulo A; Cruz C
J Pharm Sci; 2022 Aug; 111(8):2230-2238. PubMed ID: 35182543
[TBL] [Abstract][Full Text] [Related]
64. Editorial: Reviews in reproductive epidemiology: 2022.
Papatheodorou S; Benetou V
Front Reprod Health; 2023; 5():1287513. PubMed ID: 38023533
[No Abstract] [Full Text] [Related]
65. Common Microbial Genital Infections and Their Impact on the Innate Immune Response to HPV in Cervical Cells.
Fracella M; Oliveto G; Sorrentino L; Roberto P; Cinti L; Viscido A; Di Lella FM; Giuffrè F; Gentile M; Pietropaolo V; Prezioso C; Palma E; Recine N; Palaia I; Scagnolari C; Antonelli G; Pierangeli A
Pathogens; 2022 Nov; 11(11):. PubMed ID: 36422611
[TBL] [Abstract][Full Text] [Related]
66. Microbiological and behavioral determinants of genital HPV infections among adolescent girls and young women warrant the need for targeted policy interventions to reduce HPV risk.
Onywera H; Mabunda SA; Williamson AL; Mbulawa ZZA
Front Reprod Health; 2022; 4():887736. PubMed ID: 36303664
[TBL] [Abstract][Full Text] [Related]
67. BV associated bacteria specifically BVAB 1 and BVAB 3 as biomarkers for HPV risk and progression of cervical neoplasia.
Naidoo K; Abbai N; Tinarwo P; Sebitloane M
Infect Dis Obstet Gynecol; 2022; 2022():9562937. PubMed ID: 35996693
[TBL] [Abstract][Full Text] [Related]
68. Prevotella as the hub of the cervicovaginal microbiota affects the occurrence of persistent human papillomavirus infection and cervical lesions in women of childbearing age via host NF-κB/C-myc.
Dong B; Huang Y; Cai H; Chen Y; Li Y; Zou H; Lin W; Xue H; Feng A; Zhao H; Lu Y; Gao H; Mao X; Wu Z; Pan D; Sun P
J Med Virol; 2022 Nov; 94(11):5519-5534. PubMed ID: 35835717
[TBL] [Abstract][Full Text] [Related]
69. The prevalence and genotype distribution of human papillomavirus in central Fujian Province during the COVID-19 pandemic.
Lin B; Zhang F; Liu F; Huang L; Xie S; Lin Q; Liu J
Virol J; 2024 Jun; 21(1):129. PubMed ID: 38840267
[TBL] [Abstract][Full Text] [Related]
70. Microbiome markers in HPV-positive and HPV-negative women of reproductive age with ASCUS and SIL determined by V4 region of 16S rRNA gene sequencing.
Peremykina A; Cheranev V; Krivoy A; Andreev AO; Repinskaia Z; Asaturova AV; Korostin D; Rebrikov D; Bayramova GR
Front Microbiol; 2024; 15():1334502. PubMed ID: 38550866
[TBL] [Abstract][Full Text] [Related]
71. High-risk human papillomavirus prevalence among South African women diagnosed with other STIs and BV.
Qulu W; Mtshali A; Osman F; Ndlela N; Ntuli L; Mzobe G; Naicker N; Garrett N; Rompalo A; Mindel A; Ngcapu S; Liebenberg L
PLoS One; 2023; 18(11):e0294698. PubMed ID: 38032961
[TBL] [Abstract][Full Text] [Related]
72. Prevalence and genotype distribution of human papillomavirus infections in Beijing, China between 2016 and 2020.
Zhang W; Guo N; Li B; Shang E; Wang J; Zhang M; Yang X
Virol J; 2023 Jan; 20(1):11. PubMed ID: 36653807
[TBL] [Abstract][Full Text] [Related]
73. A cross-sectional analysis about bacterial vaginosis, high-risk human papillomavirus infection, and cervical intraepithelial neoplasia in Chinese women.
Xu X; Zhang Y; Yu L; Shi X; Min M; Xiong L; Pan J; Liu P; Wu G; Gao G
Sci Rep; 2022 Apr; 12(1):6609. PubMed ID: 35459771
[TBL] [Abstract][Full Text] [Related]
74. The vaginal microbiota among the different status of human papillomavirus infection and bacterial vaginosis.
Liu Y; Li T; Guo R; Chen T; Wang S; Wu D; Li J; Liu Z; Zhao Y; Yin J; Qin J; Sun L; Chen W
J Med Virol; 2023 Mar; 95(3):e28595. PubMed ID: 36811337
[TBL] [Abstract][Full Text] [Related]
75. Detection of Oncogenic Human Papillomavirus (HPV-16 and HPV-18) from Bacterial Vaginosis Positive Patient Attending at Tertiary Care Hospital in Mymensingh.
Paul A; Sarker S; Banik BC; Paul A; Paul SK; Nasreen SA; Haque N; Ahmed S; Khanam J; Arafa P; Nila SS; Chowdhury CS; Das AK; Das K
Mymensingh Med J; 2023 Oct; 32(4):959-967. PubMed ID: 37777887
[TBL] [Abstract][Full Text] [Related]
76. Association between the human papillomavirus, bacterial vaginosis and cervicitis and the detection of abnormalities in cervical smears from teenage girls and young women.
Caixeta RC; Ribeiro AA; Segatti KD; Saddi VA; Figueiredo Alves RR; dos Santos Carneiro MA; Rabelo-Santos SH
Diagn Cytopathol; 2015 Oct; 43(10):780-5. PubMed ID: 26173042
[TBL] [Abstract][Full Text] [Related]
77. Meta-analysis of the correlation between vaginal microenvironment and HPV infection.
Fu J; Zhang H
Am J Transl Res; 2023; 15(2):630-640. PubMed ID: 36915746
[TBL] [Abstract][Full Text] [Related]
78. The prevalence of human papillomavirus and bacterial vaginosis among young women in China: a cross-sectional study.
Lin W; Zhang Q; Chen Y; Chen L; Dong B; Sun P
BMC Womens Health; 2021 Dec; 21(1):409. PubMed ID: 34886845
[TBL] [Abstract][Full Text] [Related]
79.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
80.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
